OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

QPR 2007 is indeed shaping up to be a defining year for OXB the crucial question is in this cash rich, bio-hungry, pharma-pond in which little OXB swim - how on earth do they survive and retain their independence. Tough.

This deal and all the other Lenti deals, the Wyeth collab the pending TroVax deal all help - but the neuro pipeline lifts this Bio into a different league: The Premiership. The SP will reflect that within the next 6-8 months. It's a pity but it looks like ProSavin will have to wait until H2 07. Hey-ho plenty more excitement besides for sure and let's not get too greedy, eh! ;o).

What a nugget.